Key facts
- This page summarizes Peter Anevski's Form 4 filing for Progyny, Inc. (PGNY).
- 4 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 18 May 2023, 19:21.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Shares, units, or other non-derivative securities reported in this filing.
Options Exercise
Sale
Sale
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
Options Exercise
Additional SEC filing notes
Rule 10b5-1 trading plan
These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.
Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).
Footnote F1
Shares sold pursuant to a Rule 10b5-1 trading plan entered into on July 6, 2022.
Footnote F2
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.35 to $36.31, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Footnote F3
The reportable securities are held directly by the PECO ANEVSKI 2020 SD LLC.
Footnote F4
These shares will become fully vested and exercisable on May 23, 2023.